News & Updates

Breast cancer patients see no excess risk of ischaemic heart disease (IHD)-related mortality after radiotherapy (RT) treatment, according to a recent Singapore study.

The addition of ixazomib to cyclophosphamide-dexamethasone treatment does not seem to result in better survival and response rates in patients with newly diagnosed and relapsed multiple myeloma (MM), a recent study has found.

For patients with a history of cancer, exercising appears to lower the risk of contracting COVID-19 infection, according to a study.

A topical formulation containing chitosan-coated Chamomilla recutita (L.) rauschert microparticles does not lower any grade of radiodermatitis (RD) but is effective in reducing grade ≥2 toxicity to improve skin recovery and diminish high-intensity local symptoms in women with breast cancer, a study has shown.